Methyl 2-amino-4-isobutylthiophene-3-carboxylate, 95%, 2.5g

4-(4-(3-(Pyridin-2-yl)-1H-pyrazol-4-yl)pyridin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)benzamide, 95%, 10mg

3-BROMO-4-FLUORO-N,N-DIMETHYL-BENZAMIDE, 95.0%, 2g

3-Acetyl-7(1H)-azaindole, 95.0%, 10g

2-Chloro-4-(trifluoromethyl)benzo[d]thiazole, 95.0%, 250mg

Diethyl N-(tert-Butoxycarbonyl)phosphoramidate>98.0%(HPLC)(N)5g

3-Amino-2,5,6-trifluorobenzonitrile, 95.0%, 250mg

3-Chloro-3',4,4'-trifluorobenzophenone, 97.0%, 1g

3-Methoxy-2-(trifluoromethyl)benzaldehyde, 250mg

Recipientes esterilizables en autoclave con tapa cilíndrica, 19 l, 1 unidad

Matraces aforados clase A Vidrio transparente, 10 ml, 10/19, 2 unidad(es), 2 Pieza(s)

tert-Butyl 4-oxohexahydrocyclopenta[c]pyrrole-2(1H)-carboxylate, 95.0%, 100mg

(5E)-5-(3-isopropoxybenzylidene)-2-mercapto-1,3-thiazol-4(5H)-one, 95.0%, 5g